Insider trade

Becton Dickinson (BDX): Officer sold ~$141K

Michael David Garrison, Officer at Becton Dickinson, sold ~$141K of Becton Dickinson shares.

~$141K
Approx. value · 597 sh @ $236.51
5,544
Holds after · shares reported
Traded
Jan 17, 2025
Filed
Jan 21, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 5, 2024InsiderOfficer sold ~$330K of BDX shares in the open market
  2. Dec 6, 2024Insider · 2 peopleInsiders: 2 sales (~$1.2M)
  3. Dec 9, 2024InsiderOfficer sold ~$140K of BDX shares in the open market
  4. Dec 19, 2024InsiderOfficer sold ~$634K of BDX shares in the open market
  5. Jan 7, 2025InsiderOfficer sold ~$185K of BDX shares in the open market
  6. Jan 17, 2025 · this disclosureInsiderOfficer sold ~$141K of BDX shares in the open market

What came next

  1. Jan 21, 2025Insider · 2 peopleInsiders: 2 sales (~$309K)
  2. Feb 10, 2025InsiderDirector purchased ~$350K of BDX shares in the open market
  3. Feb 12, 2025InsiderDirector sold ~$160K of BDX shares in the open market
  4. Mar 5, 2025CongressDisclosed sale of BDX — reported range $15,001 - $50,000
  5. Mar 12, 2025InsiderOfficer sold ~$436K of BDX shares in the open market
  6. Mar 18, 2025InsiderOfficer sold ~$106K of BDX shares in the open market
  7. Mar 21, 2025FDAFDA device clearance: BD Vacutainer® Multiple Sample Luer Adapter
  8. Mar 24, 2025FDAFDA device clearance: UltraCor™ Twirl™ Breast Tissue Marker
  9. Apr 8, 2025CongressDisclosed sale of BDX — reported range $1,001 - $15,000
  10. Apr 9, 2025FDAFDA device clearance: CentroVena Central Venous Catheter (CVC) with the CentroVena One Insertion System
  11. Apr 9, 2025FDAFDA device clearance: Bard Soft Mesh; Bard Soft Mesh Pre-Shaped
  12. Apr 9, 2025InsiderOfficer sold ~$94K of BDX shares in the open market
  13. Apr 17, 2025FDARecall: Bard¿ Single Intragastric Linton Balloon Tube, REF: 0092740
  14. Apr 17, 2025FDARecall: Bard¿ Blakemore Esophageal-Nasogastric Tube (Intermediate)REF: 0092300
  15. Apr 17, 2025FDARecall: Bard¿ Blakemore Esophageal-Nasogastric Tube (Child) REF: 0092110
  16. Apr 17, 2025FDARecall: Bard Minnesota Four Lumen Esophagogastric Tamponade Tube, REF:0092220 18 Fr. (6mm, 7/32"), 41" Length (104cm) with 8" (20.3cm) Balloon X-Ray Opaque Rubber
  17. Apr 17, 2025FDARecall: Bard Blakemore Esophageal-Nasogastric Tube (Adult) REF: 0092100
  18. Apr 21, 2025FDARecall: BD Cathena Safety IV Catheter BD Multiguard Technology 18 GA x 1.25 IN, REF: 386865; BD Cathena Safety IV Catheter 20GX1.00IN STRAIGHT BC, REF: 386803; BD Cath…
  19. Apr 25, 2025FDAFDA device clearance: BD Alaris Infusion System with Guardrails Suite MX
  20. May 8, 2025FDARecall: Product Name [REF]: Supply Server, CCE Enterprise SW Site License (2-5), BD Pyxis Logistics [806], BD Pyxis MedStation 4000 Main 10885403512629 [303], BD Pyxis…
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Becton Dickinson

For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.

Other recent filings by Michael David Garrison, EVP & President, Medical

The full history of Michael David Garrison, EVP & President, Medical is on the profile page.

How this filing works

Explore the data

Common questions

Which Becton Dickinson (BDX) insider traded, and how much?

Michael David Garrison, Officer at Becton Dickinson, sold ~$141K of Becton Dickinson shares. 597 shares at $236.51.

When did it happen, and when was it made public?

Traded: Jan 17, 2025. Filed: Jan 21, 2025. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Becton Dickinson recently?

For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BDX page.

Does this mean BDX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Becton Dickinson

Everything OQRO holds on this company is on its BDX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data